B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin (Q30525106)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Stamatis-Nick Liossis

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Dimitrios Daoussis

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Athanassios C Tsamandas

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Ioannis Antonopoulos

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Elli Karatza

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Georgios Yiannopoulos

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Andrew P Andonopoulos

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

14 June 2012

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Arthritis Research and Therapy

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

R145

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

Regulation of PDGF and its receptors in fibrotic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTestTM in breast carcinoma by image analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446529

14 July 2018

Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study

1 reference

https://api.crossref.org/works/10.1186%2FAR3879

21 January 2018

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1186%2FAR3879

21 January 2018

Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.

1 reference

https://api.crossref.org/works/10.1186%2FAR3879

21 January 2018

Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis

1 reference

https://api.crossref.org/works/10.1186%2FAR3879

21 January 2018

Expression of platelet-derived growth factor B-chain and platelet-derived growth factor beta-receptor in fibroblasts of scleroderma.

1 reference

https://api.crossref.org/works/10.1186%2FAR3879

21 January 2018

The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study.

1 reference

https://api.crossref.org/works/10.1186%2FAR3879

21 January 2018

Increased expression of platelet-derived growth factor type b receptors in the skin of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1186%2FAR3879

21 January 2018

Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22697462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22697462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased Plasma Levels of Platelet-Derived Growth Factor Activity in Patients with Progressive Systemic Sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22697462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22697462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22697462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model

1 reference

https://pubmed.ncbi.nlm.nih.gov/22697462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22697462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections

1 reference

https://pubmed.ncbi.nlm.nih.gov/22697462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22697462%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30525106&oldid=2175379281"